Activase (alteplase) - Roche, Boehringer Ingelheim, Kyowa Kirin, Tanabe Pharma
CHOICE2: CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2). (clinicaltrials.gov) - Sep 19, 2026 - P3 | N=440 | Completed | Sponsor: Hospital Clinic of Barcelona | Active, not recruiting ➔ Completed 
Trial completion • Cardiovascular • Ischemic stroke
http://clinicaltrials.gov/ct2/show/NCT05797792
 
Sep 19, 2026
 
Prev Next